The success of Merck’s antiviral—and other COVID-19 pills in development—may depend on how quickly people start taking them
October 14, 2021 at 13:17 PM EDT
Researchers are hopeful that these pills may also be able to reduce how long someone is infectious or sick—or even prevent people from ending up with long COVID.
